Hepatocellular carcinoma in central Sydney: a 10 year review of patients seen in a medical oncology department

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 6

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

216

HTML

1736

Tables (1-3)

116

Sum=2068

Dec 15, 1999 (publication date) through Apr 25, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Articles

World J Gastroenterol. Dec 15, 1999; 5(6): 483-487
Published online Dec 15, 1999. doi: 10.3748/wjg.v5.i6.483

Table 3 Summary of treatments received for hepatocellular carcinoma

Treatment	Number of patients (%)	Number responding (%)	Median time to progression (weeks)
Observation	20 (30)
Surgery	16 (25)	16 (100)	43
Chemoembolization	11 (17)	6 (54)	25
Systemic chemotherapy	12 (19)	2 (27)	26
Tamoxifen	25 (40)	1 (4)	44

Citation: Yip D, Findlay M, Boyer M, Tattersall MH. Hepatocellular carcinoma in central Sydney: a 10 year review of patients seen in a medical oncology department. World J Gastroenterol 1999; 5(6): 483-487
URL: https://www.wjgnet.com/1007-9327/full/v5/i6/483.htm
DOI: https://dx.doi.org/10.3748/wjg.v5.i6.483